Brizuela Aritza, Martín Nerea, Fernández-Gonzalez Felipe J, Larrazábal Carolina, Anta Alberto
DDS,PhD,MsC. Professor, Postgraduate Department of Oral Implantology, School of Medicine and Dentistry, University of the Basque Country, Leioa, Spain.
DDS. Professor, Department of Integrated Adult Dentistry, Department of Stomatology, School of Medicine and Dentistry, University of the Basque Country, Leioa, Spain.
J Clin Exp Dent. 2014 Dec 1;6(5):e479-84. doi: 10.4317/jced.51576. eCollection 2014 Dec.
The aim of this prospective clinical trial was to evaluate the success implant rates during 24 months using OSFE procedure without grafting materials.
42 adult patients (22 female, 15 male) were selected according to Nedir et al´s inclusion criteria of which 5 patients were excluded, due to periapical pathology in adjacent teeth (n=3) and treatment with bisphosphonates (n=2). 37 patients aged 31-68 years were selected. Smokers were divided in two groups depending on the number of cigarettes consumed per day (a) 0-10, (b) 11-20. One patient was excluded because he was lost to follow-up at 24 months A total of 36 threaded implants were placed, ∅4,1mm Straumann® (Straumann AG, Waldenburg, Switzerland) and ∅3,5mm Klockner® (Klockner Implant System, Barcelona, Spain). The most used implant diameter was 4,1 mm (n=29), followed by 3,5 mm (n=7), and length used was 10 mm (n=32) and 8 mm (n=4). Initial RBH ranged from 4 mm to 9 mm. All statistical data were processed using the program R 3.0.2 for windows.
A total of 36 threaded implants were placed. Residual bone height (RBH) at implant placement averaged 7,4 ± 0,4 mm. Mean bone gain was 1,8 ± 0,3 mm. Four implants showed a bone gain exceeding 3 mm. Mean implant protrusion length into the sinus amounted to 2.1 ± 0,3 mm. Regarding the relationship between smoking and periodontal probes, no statistically significant differences were found (P=0,25), neither in relation to the number of threads that the implants showed (P=0,29) or bone gain (P=0,79). After 24 months the implant success rate was 91,6%.
Implant rehabilitation of edentulous atrophied posterior maxilla can be safely performed and simplified using the OSFE technique without grafting with reliable long-term results. Key words:Crestal bone loss, dental implants, internal sinus lift, no grafting, osteotome sinus elevation, grafting, sinus floor elevation.
这项前瞻性临床试验的目的是评估使用无移植材料的骨劈开上颌窦底提升术(OSFE)在24个月内的种植成功率。
根据Nedir等人的纳入标准选择了42例成年患者(22例女性,15例男性),其中5例患者因邻牙根尖周病变(n = 3)和双膦酸盐治疗(n = 2)被排除。最终选取了37例年龄在31 - 68岁的患者。吸烟者根据每日吸烟量分为两组:(a)0 - 10支,(b)11 - 20支。有1例患者因在24个月时失访被排除。总共植入了36颗螺纹种植体,直径4.1mm的Straumann®(瑞士沃登堡的Straumann AG公司)和直径3.5mm的Klockner®(西班牙巴塞罗那的Klockner种植系统公司)。最常用的种植体直径为4.1mm(n = 29),其次是3.5mm(n = 7),使用的长度为10mm(n = 32)和8mm(n = 4)。初始剩余骨高度(RBH)范围为4mm至9mm。所有统计数据均使用适用于Windows的R 3.0.2程序进行处理。
总共植入了36颗螺纹种植体。种植时的平均剩余骨高度(RBH)为7.4±0.4mm。平均骨增量为1.8±0.3mm。有4颗种植体的骨增量超过3mm。种植体突入上颌窦的平均长度为2.1±0.3mm。关于吸烟与牙周探针的关系,未发现统计学上的显著差异(P = 0.25),种植体的螺纹数量(P = 0.29)或骨增量(P = 0.79)方面也未发现显著差异。24个月后种植成功率为91.6%。
使用骨劈开上颌窦底提升术(OSFE)技术,无需移植材料,可安全、简化地对上颌后牙区无牙萎缩患者进行种植修复,并能获得可靠的长期效果。关键词:牙槽骨吸收、牙种植体、上颌窦内提升、无移植、骨凿上颌窦提升、移植、上颌窦底提升